ArticleProstate cancer2014
Prostate cancer in South Africa: pathology based national cancer registry data (1986-2006) and mortality rates (1997-2009).
Article in Prostate cancer, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 20 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 1 synthesis or guideline pooled it.
- An Estimate of the Incidence of Prostate Cancer in Africa: A Systematic Review and Meta-Analysis.PloS one · 2016Pooled it
- Challenges of data quality for the management of prostate cancer in Tanzania: A hurdle towards improving the quality of service.PLOS global public health · 2025Article
- Treatment approaches for prostate cancer in sub-Saharan Africa.Translational cancer research · 2024Review
- Prostate cancer knowledge and barriers to screening among men at risk in northern Tanzania: A community-based study.Cancer treatment and research communications · 2024Article
- The profile of Black South African men diagnosed with prostate cancer in the Free State, South Africa.South African family practice : official journal of the South African Academy of Family Practice/Primary Care · 2023Article
- Prostate Cancer Review: Genetics, Diagnosis, Treatment Options, and Alternative Approaches.Molecules (Basel, Switzerland) · 2022Review
- Article
- A modified Delphi study to identify screening items to assess neglected sexual side-effects following prostate cancer treatment.BMC urology · 2022Article
- Editorial: Application of biostatistics and epidemiological methods for cancer research in Sub-Saharan Africa.Frontiers in public health · 2022Article
- Prostate Cancer Patterns and Trends in the Eastern Cape Province of South Africa; 1998-2017.Frontiers in public health · 2022Article
- Prostate Cancer Disparities and Management in Southern Africa: Insights into Practices, Norms and Values.Cancer management and research · 2022Review
- Diagnostic Performance ofThe world journal of men's health · 2020Article
- Encapsulation of Variabilin in Stearic Acid Solid Lipid Nanoparticles Enhances Its Anticancer Activity in Vitro.Molecules (Basel, Switzerland) · 2020Article
- Mining laboratory data to describe prostate specific antigen testing and prostate cancer in Johannesburg, South Africa.The Pan African medical journal · 2020Article
- Article
- Computational Modeling of complete HOXB13 protein for predicting the functional effect of SNPs and the associated role in hereditary prostate cancer.Scientific reports · 2017Article
- What Prevents Men Aged 40-64 Years from Prostate Cancer Screening in Namibia?Journal of cancer epidemiology · 2016Article
- South African National Cancer Registry: Effect of withheld data from private health systems on cancer incidence estimates.South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde · 2015Article
- Cancer mortality pattern in lagos university teaching hospital, lagos, Nigeria.Journal of cancer epidemiology · 2015Article
- Depression, Anxiety, and Their Association to Health-Related Quality of Life in Men Commencing Prostate Cancer Treatment at Tertiary Hospitals in Cape Town, South Africa.Cancer control : journal of the Moffitt Cancer CenterObservational
Corrections and comments
- Erratum issued
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Prostate cancer is one of the most common male cancers globally; however little is known about prostate cancer in Africa. Incidence data for prostate cancer in South Africa (SA) from the pathology based National Cancer Registry (1986-2006) and data on mortality (1997-2009) from Statistics SA were analysed. World standard population denominators were used to calculate age specific incidence and mortality rates (ASIR and ASMR) using the direct method. Prostate cancer was the most common male cancer in all SA population groups (excluding basal cell carcinoma). There are large disparities in the ASIR between black, white, coloured, and Asian/Indian populations: 19, 65, 46, and 19 per 100 000, respectively, and ASMR was 11, 7, 52, and 6 per 100 000, respectively. Prostate cancer was the second leading cause of cancer death, accounting for around 13% of male deaths from a cancer. The average age at diagnosis was 68 years and 74 years at death. For SA the ASIR increased from 16.8 in 1986 to 30.8 in 2006, while the ASMR increased from 12.3 in 1997 to 16.7 in 2009. There has been a steady increase of incidence and mortality from prostate cancer in SA.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.